We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

96 hedge funds and large institutions have $12.4M invested in Zomedica Corp. in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

0% less capital invested

Capital invested by funds: $12.4M → $12.4M (-$21.3K)

3% less funds holding

Funds holding: 9996 (-3)

Holders
96
Holders Change
-3
Holders Change %
-3.03%
% of All Funds
1.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
16
Reduced
16
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EW
101
Evexia Wealth
Wisconsin
-$4.72K -35,000 Closed
Carson Wealth (CWM LLC)
102
Carson Wealth (CWM LLC)
Nebraska
-$5.09K -34,000 -97%
Millennium Management
103
Millennium Management
New York
-$4.38K -29,987 Closed
Goldman Sachs
104
Goldman Sachs
New York
-$2.39K -16,391 Closed
BRWA
105
B. Riley Wealth Advisors
Florida
-$1.67K -10,000 Closed
TFS
106
Thoroughbred Financial Services
Tennessee
-$1K -10,000 Closed
GPFA
107
Game Plan Financial Advisors
Ohio
-$438 -3,000 Closed
SWA
108
SOA Wealth Advisors
New York
-$158 -1,084 Closed
Royal Bank of Canada
109
Royal Bank of Canada
Ontario, Canada
+$479 +3,200 +359%

ZOM Hedge Fund Activity: Q2 2024 in Review

96 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2024, worth a combined $12.4M — down 0.17% from $12.4M a quarter earlier.

Fund positioning in ZOM was balanced in Q2 2024: 13 funds opened new positions, 13 closed out, 16 added to existing stakes and 16 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $412K. The largest seller was Atom Investors, exiting entirely with an estimated $175K sold.

  • 96 institutional investors held Zomedica Corp. (ZOM) as of Q2 2024, down from 99 in Q1 2024.
  • Funds reported $12.4M of Zomedica Corp. stock for Q2 2024, down 0.17% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q2 2024 and 13 closed out, a net change of 0 holders.
  • The largest Zomedica Corp. buyer in Q2 2024 was GSA Capital Partners, an estimated $412K added.
  • The largest Zomedica Corp. seller in Q2 2024 was Atom Investors, an estimated $175K sold.

Based on aggregated 13F filings for Q2 2024.